Profiel
Jason S.
Kim worked as the Director of Business Development at ImClone LLC from 2003 to 2006.
He then served as the Director of Business & Corporate Development at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Jason also worked as an Associate at Safeguard Scientifics, Inc. and Domain Associates LLC.
From 2010 to 2017, he held the position of President & Chief Financial Officer at Molecular Templates, Inc. In 2023, he became the President, CFO, CAO & Treasurer at Molecular Templates, Inc. Jason also served as the Chief Operating Officer at Molecular Templates OpCo, Inc. Mr. Kim completed his undergraduate studies at Wesleyan University and earned an MBA from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Jason Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Financieel Directeur/CFO | 08-12-2024 |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Financieel Directeur/CFO | 01-08-2017 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2011 |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Corporate Officer/Principal | 01-01-2009 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01-01-2006 |
Opleiding van Jason Kim
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Safeguard Scientifics, Inc.
Safeguard Scientifics, Inc. Investment ManagersFinance Invests in technology companies | Finance |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
















